{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T18:21:53Z","timestamp":1793816513983,"version":"4.6.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":79,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Kangdong Sacred Heart Hospital Fund","award":["Grant No. 2024-08"],"award-info":[{"award-number":["Grant No. 2024-08"]}]},{"name":"Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education","award":["RS-2023-00243252"],"award-info":[{"award-number":["RS-2023-00243252"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-57929-w","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T14:54:46Z","timestamp":1781621686000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Anti-fibrotic effects of evogliptin in fibroblasts derived from post-burn hypertrophic scars"],"prefix":"10.1038","volume":"16","author":[{"given":"Youn Kyung","family":"Kee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"June-Bum","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya Xin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui Song","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoon Soo","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So Young","family":"Joo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu Mi","family":"Ro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In Suk","family":"Kwak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheong Hoon","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,16]]},"reference":[{"key":"57929_CR1","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1111\/jnu.12563","volume":"52","author":"J Bayuo","year":"2020","unstructured":"Bayuo, J., Wong, F. K. Y. & Agyei, F. B. On the recovery journey: an integrative review of the needs of burn patients from immediate pre-discharge to post-discharge period using the Omaha system. J. Nurs. Scholarsh. 52, 360\u2013368. https:\/\/doi.org\/10.1111\/jnu.12563 (2020).","journal-title":"J. Nurs. Scholarsh."},{"key":"57929_CR2","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1016\/s0140-6736(16)31406-4","volume":"388","author":"CC Finnerty","year":"2016","unstructured":"Finnerty, C. C. et al. Hypertrophic scarring: the greatest unmet challenge after burn injury. Lancet 388, 1427\u20131436. https:\/\/doi.org\/10.1016\/s0140-6736(16)31406-4 (2016).","journal-title":"Lancet"},{"key":"57929_CR3","doi-asserted-by":"publisher","first-page":"6242","DOI":"10.1038\/s41467-021-26495-2","volume":"12","author":"V Vorstandlechner","year":"2021","unstructured":"Vorstandlechner, V. et al. The serine proteases dipeptidyl-peptidase 4 and urokinase are key molecules in human and mouse scar formation. Nat. Commun. 12, 6242. https:\/\/doi.org\/10.1038\/s41467-021-26495-2 (2021).","journal-title":"Nat. Commun."},{"key":"57929_CR4","doi-asserted-by":"publisher","unstructured":"Jiang, D., Guo, R., Machens, H. G. & Rinkevich, Y. Diversity of fibroblasts and their roles in wound healing. Cold Spring Harb Perspect. Biol. 15 https:\/\/doi.org\/10.1101\/cshperspect.a041222 (2023).","DOI":"10.1101\/cshperspect.a041222"},{"key":"57929_CR5","doi-asserted-by":"publisher","first-page":"C1545","DOI":"10.1152\/ajpcell.00254.2023","volume":"325","author":"S Faour","year":"2023","unstructured":"Faour, S., Farahat, M., Aijaz, A. & Jeschke, M. G. Fibrosis in burns: an overview of mechanisms and therapies. Am. J. Physiol. Cell. Physiol. 325, C1545\u2013c1557. https:\/\/doi.org\/10.1152\/ajpcell.00254.2023 (2023).","journal-title":"Am. J. Physiol. Cell. Physiol."},{"key":"57929_CR6","doi-asserted-by":"publisher","unstructured":"Schuster, R., Younesi, F., Ezzo, M. & Hinz, B. The role of myofibroblasts in physiological and pathological tissue repair. Cold Spring Harb Perspect. Biol. 15 https:\/\/doi.org\/10.1101\/cshperspect.a041231 (2023).","DOI":"10.1101\/cshperspect.a041231"},{"key":"57929_CR7","doi-asserted-by":"publisher","first-page":"37530","DOI":"10.1021\/acsami.4c05731","volume":"16","author":"H Huang","year":"2024","unstructured":"Huang, H. et al. Graphene quantum dots reduce hypertrophic scar by inducing myofibroblasts to be a quiescent state. ACS Appl. Mater. Interfaces. 16, 37530\u201337544. https:\/\/doi.org\/10.1021\/acsami.4c05731 (2024).","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"57929_CR8","doi-asserted-by":"publisher","first-page":"e20190103","DOI":"10.1084\/jem.20190103","volume":"217","author":"N Frangogiannis","year":"2020","unstructured":"Frangogiannis, N. Transforming growth factor-\u03b2 in tissue fibrosis. J. Exp. Med. 217, e20190103. https:\/\/doi.org\/10.1084\/jem.20190103 (2020).","journal-title":"J. Exp. Med."},{"key":"57929_CR9","doi-asserted-by":"publisher","unstructured":"Zhang, Y. E. Non-smad signaling pathways of the TGF-\u03b2 family. Cold Spring Harb Perspect. Biol. 9 https:\/\/doi.org\/10.1101\/cshperspect.a022129 (2017).","DOI":"10.1101\/cshperspect.a022129"},{"key":"57929_CR10","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1093\/rheumatology\/kex347","volume":"57","author":"M Pedroza","year":"2018","unstructured":"Pedroza, M. et al. Role of STAT3 in skin fibrosis and transforming growth factor beta signalling. Rheumatol. (Oxford). 57, 1838\u20131850. https:\/\/doi.org\/10.1093\/rheumatology\/kex347 (2018).","journal-title":"Rheumatol. (Oxford)"},{"key":"57929_CR11","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1111\/iwj.12283","volume":"13","author":"Q Chun","year":"2016","unstructured":"Chun, Q., ZhiYong, W., Fei, S. & XiQiao, W. Dynamic biological changes in fibroblasts during hypertrophic scar formation and regression. Int. Wound J. 13, 257\u2013262. https:\/\/doi.org\/10.1111\/iwj.12283 (2016).","journal-title":"Int. Wound J."},{"key":"57929_CR12","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.jhep.2015.04.011","volume":"63","author":"I Mannaerts","year":"2015","unstructured":"Mannaerts, I. et al. The Hippo pathway effector YAP controls mouse hepatic stellate cell activation. J. Hepatol. 63, 679\u2013688. https:\/\/doi.org\/10.1016\/j.jhep.2015.04.011 (2015).","journal-title":"J. Hepatol."},{"key":"57929_CR13","doi-asserted-by":"publisher","first-page":"13484","DOI":"10.1038\/s41598-021-92871-z","volume":"11","author":"R Nakamura","year":"2021","unstructured":"Nakamura, R., Hiwatashi, N., Bing, R., Doyle, C. P. & Branski, R. C. Concurrent YAP\/TAZ and SMAD signaling mediate vocal fold fibrosis. Sci. Rep. 11, 13484. https:\/\/doi.org\/10.1038\/s41598-021-92871-z (2021).","journal-title":"Sci. Rep."},{"key":"57929_CR14","doi-asserted-by":"publisher","first-page":"110144","DOI":"10.1016\/j.intimp.2023.110144","volume":"118","author":"Y Zhao","year":"2023","unstructured":"Zhao, Y. et al. LXA4 inhibits TGF-\u03b21-induced airway smooth muscle cells proliferation and migration by suppressing the Smad\/YAP pathway. Int. Immunopharmacol. 118, 110144. https:\/\/doi.org\/10.1016\/j.intimp.2023.110144 (2023).","journal-title":"Int. Immunopharmacol."},{"key":"57929_CR15","doi-asserted-by":"publisher","first-page":"3326","DOI":"10.1016\/j.ajpath.2015.08.011","volume":"185","author":"B Piersma","year":"2015","unstructured":"Piersma, B. et al. YAP1 is a driver of myofibroblast differentiation in normal and diseased fibroblasts. Am. J. Pathol. 185, 3326\u20133337. https:\/\/doi.org\/10.1016\/j.ajpath.2015.08.011 (2015).","journal-title":"Am. J. Pathol."},{"key":"57929_CR16","doi-asserted-by":"publisher","first-page":"C1015","DOI":"10.1152\/ajpcell.00541.2024","volume":"328","author":"FS Gallardo","year":"2025","unstructured":"Gallardo, F. S. et al. Role of TGF-\u03b2\/SMAD\/YAP\/TAZ signaling in skeletal muscle fibrosis. Am. J. Physiol. Cell. Physiol. 328, C1015\u2013c1028. https:\/\/doi.org\/10.1152\/ajpcell.00541.2024 (2025).","journal-title":"Am. J. Physiol. Cell. Physiol."},{"key":"57929_CR17","doi-asserted-by":"publisher","first-page":"3431","DOI":"10.1038\/s41467-023-39129-6","volume":"14","author":"Y Zhang","year":"2023","unstructured":"Zhang, Y. et al. Scarless wound healing programmed by core-shell microneedles. Nat. Commun. 14, 3431. https:\/\/doi.org\/10.1038\/s41467-023-39129-6 (2023).","journal-title":"Nat. Commun."},{"key":"57929_CR18","doi-asserted-by":"publisher","first-page":"aaa2151","DOI":"10.1126\/science.aaa2151","volume":"348","author":"Y Rinkevich","year":"2015","unstructured":"Rinkevich, Y. et al. Skin fibrosis. Identification and isolation of a dermal lineage with intrinsic fibrogenic potential. Science 348, aaa2151. https:\/\/doi.org\/10.1126\/science.aaa2151 (2015).","journal-title":"Science"},{"key":"57929_CR19","doi-asserted-by":"publisher","first-page":"e70090","DOI":"10.1111\/wrr.70090","volume":"33","author":"LS Mamoun","year":"2025","unstructured":"Mamoun, L. S., Rosenbloom, A. J., Gasbeck, T., Ziegler, M. & Widgerow, A. D. From glucose to gauze: A systematic review on the various wound healing properties of DPP-4 inhibitors beyond glycaemic control. Wound Repair. Regen. 33, e70090. https:\/\/doi.org\/10.1111\/wrr.70090 (2025).","journal-title":"Wound Repair. Regen"},{"key":"57929_CR20","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/exd.13800","volume":"28","author":"Y Li","year":"2019","unstructured":"Li, Y. et al. Linagliptin inhibits high glucose-induced transdifferentiation of hypertrophic scar-derived fibroblasts to myofibroblasts via IGF\/Akt\/mTOR signalling pathway. Exp. Dermatol. 28, 19\u201327. https:\/\/doi.org\/10.1111\/exd.13800 (2019).","journal-title":"Exp. Dermatol."},{"key":"57929_CR21","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1097\/prs.0000000000006904","volume":"146","author":"H Suwanai","year":"2020","unstructured":"Suwanai, H., Watanabe, R., Sato, M., Odawara, M. & Matsumura, H. Dipeptidyl peptidase-4 inhibitor reduces the risk of developing hypertrophic scars and keloids following median sternotomy in diabetic patients: A nationwide retrospective cohort study using the National Database of Health Insurance Claims of Japan. Plast. Reconstr. Surg. 146, 83\u201389. https:\/\/doi.org\/10.1097\/prs.0000000000006904 (2020).","journal-title":"Plast. Reconstr. Surg."},{"key":"57929_CR22","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1080\/14656566.2016.1183645","volume":"17","author":"X Tan","year":"2016","unstructured":"Tan, X. & Hu, J. Evogliptin: a new dipeptidyl peptidase inhibitor for the treatment of type 2 diabetes. Expert Opin. Pharmacother. 17, 1285\u20131293. https:\/\/doi.org\/10.1080\/14656566.2016.1183645 (2016).","journal-title":"Expert Opin. Pharmacother"},{"key":"57929_CR23","doi-asserted-by":"publisher","first-page":"154","DOI":"10.4062\/biomolther.2020.150","volume":"29","author":"H Yoon","year":"2021","unstructured":"Yoon, H., Sung, J. H. & Song, M. J. Effects of the antidiabetic drugs evogliptin and sitagliptin on the immune function of CD26\/DPP4 in Th1 cells. Biomol. Ther. (Seoul). 29, 154\u2013165. https:\/\/doi.org\/10.4062\/biomolther.2020.150 (2021).","journal-title":"Biomol. Ther. (Seoul)"},{"key":"57929_CR24","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/s12276-023-00958-6","volume":"55","author":"TK Pham","year":"2023","unstructured":"Pham, T. K. et al. Evogliptin, a DPP-4 inhibitor, prevents diabetic cardiomyopathy by alleviating cardiac lipotoxicity in db\/db mice. Exp. Mol. Med. 55, 767\u2013778. https:\/\/doi.org\/10.1038\/s12276-023-00958-6 (2023).","journal-title":"Exp. Mol. Med."},{"key":"57929_CR25","doi-asserted-by":"publisher","first-page":"186","DOI":"10.4093\/dmj.2018.0271","volume":"44","author":"MJ Kim","year":"2020","unstructured":"Kim, M. J. et al. Evogliptin, a dipeptidyl peptidase-4 inhibitor, attenuates renal fibrosis caused by unilateral ureteral obstruction in mice. Diabetes Metab. J. 44, 186\u2013192. https:\/\/doi.org\/10.4093\/dmj.2018.0271 (2020).","journal-title":"Diabetes Metab. J."},{"key":"57929_CR26","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1101\/gad.1664408","volume":"22","author":"B Zhao","year":"2008","unstructured":"Zhao, B. et al. TEAD mediates YAP-dependent gene induction and growth control. Genes Dev. 22, 1962\u20131971. https:\/\/doi.org\/10.1101\/gad.1664408 (2008).","journal-title":"Genes Dev."},{"key":"57929_CR27","doi-asserted-by":"publisher","first-page":"806740","DOI":"10.3389\/fgene.2021.806740","volume":"12","author":"S Zhang","year":"2021","unstructured":"Zhang, S., Zhang, Y. & Min, P. Single-cell and bulk transcriptome data integration reveals dysfunctional cell types and aberrantly expressed genes in hypertrophic scar. Front. Genet. 12, 806740. https:\/\/doi.org\/10.3389\/fgene.2021.806740 (2021).","journal-title":"Front. Genet."},{"key":"57929_CR28","doi-asserted-by":"publisher","unstructured":"Cui, H. S. et al. Extracorporeal shock wave therapy alters the expression of fibrosis-related molecules in fibroblast derived from human hypertrophic scar. Int. J. Mol. Sci. 19 https:\/\/doi.org\/10.3390\/ijms19010124 (2018).","DOI":"10.3390\/ijms19010124"},{"key":"57929_CR29","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ejca.2022.01.004","volume":"165","author":"K Zhao","year":"2022","unstructured":"Zhao, K. et al. Morusin enhances the antitumor activity of MAPK pathway inhibitors in BRAF-mutant melanoma by inhibiting the feedback activation of STAT3. Eur. J. Cancer. 165, 58\u201370. https:\/\/doi.org\/10.1016\/j.ejca.2022.01.004 (2022).","journal-title":"Eur. J. Cancer"},{"key":"57929_CR30","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1016\/j.ajpath.2017.04.017","volume":"187","author":"W Mah","year":"2017","unstructured":"Mah, W. et al. Elevated CD26 expression by skin fibroblasts distinguishes a profibrotic phenotype involved in scar formation compared to gingival fibroblasts. Am. J. Pathol. 187, 1717\u20131735. https:\/\/doi.org\/10.1016\/j.ajpath.2017.04.017 (2017).","journal-title":"Am. J. Pathol."},{"key":"57929_CR31","doi-asserted-by":"publisher","first-page":"4169","DOI":"10.2147\/jir.S326385","volume":"14","author":"Z Chen","year":"2021","unstructured":"Chen, Z. et al. Dysregulation of DPP4-CXCL12 balance by TGF-\u03b21\/SMAD pathway promotes CXCR4(+) inflammatory cell infiltration in keloid scars. J. Inflamm. Res. 14, 4169\u20134180. https:\/\/doi.org\/10.2147\/jir.S326385 (2021).","journal-title":"J. Inflamm. Res."},{"key":"57929_CR32","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s12016-016-8578-z","volume":"56","author":"JJ Nieto-Fontarigo","year":"2019","unstructured":"Nieto-Fontarigo, J. J. et al. CD26 and asthma: a comprehensive review. Clin. Rev. Allergy Immunol. 56, 139\u2013160. https:\/\/doi.org\/10.1007\/s12016-016-8578-z (2019).","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"57929_CR33","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/s0165-2478(97)02716-8","volume":"58","author":"D Reinhold","year":"1997","unstructured":"Reinhold, D. et al. Inhibitors of dipeptidyl peptidase IV (DP IV, CD26) induces secretion of transforming growth factor-beta 1 (TGF-beta 1) in stimulated mouse splenocytes and thymocytes. Immunol. Lett. 58, 29\u201335. https:\/\/doi.org\/10.1016\/s0165-2478(97)02716-8 (1997).","journal-title":"Immunol. Lett."},{"key":"57929_CR34","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s12672-023-00815-y","volume":"14","author":"C Liu","year":"2023","unstructured":"Liu, C. et al. Down-regulation of DPP4 by TGF\u03b21\/miR29a-3p inhibited proliferation and promoted migration of ovarian cancer cells. Discov Oncol. 14, 195. https:\/\/doi.org\/10.1007\/s12672-023-00815-y (2023).","journal-title":"Discov Oncol."},{"key":"57929_CR35","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1089\/thy.2022.0317","volume":"32","author":"Q He","year":"2022","unstructured":"He, Q. et al. Dipeptidyl peptidase-4 stabilizes integrin \u03b14\u03b21 complex to promote thyroid cancer cell metastasis by activating transforming growth factor-beta signaling pathway. Thyroid 32, 1411\u20131422. https:\/\/doi.org\/10.1089\/thy.2022.0317 (2022).","journal-title":"Thyroid"},{"key":"57929_CR36","doi-asserted-by":"publisher","first-page":"e2406153","DOI":"10.1002\/adma.202406153","volume":"36","author":"M Liu","year":"2024","unstructured":"Liu, M. et al. A strategy involving microporous microneedles integrated with CAR-TREM2-macrophages for scar management by regulating fibrotic microenvironment. Adv. Mater. 36, e2406153. https:\/\/doi.org\/10.1002\/adma.202406153 (2024).","journal-title":"Adv. Mater."},{"key":"57929_CR37","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.matbio.2024.02.009","volume":"128","author":"P Chitturi","year":"2024","unstructured":"Chitturi, P. & Leask, A. The role of positional information in determining dermal fibroblast diversity. Matrix Biol. 128, 31\u201338. https:\/\/doi.org\/10.1016\/j.matbio.2024.02.009 (2024).","journal-title":"Matrix Biol."},{"key":"57929_CR38","doi-asserted-by":"publisher","first-page":"3766","DOI":"10.1038\/s41467-020-17556-z","volume":"11","author":"LL Baggio","year":"2020","unstructured":"Baggio, L. L. et al. Plasma levels of DPP4 activity and sDPP4 are dissociated from inflammation in mice and humans. Nat. Commun. 11, 3766. https:\/\/doi.org\/10.1038\/s41467-020-17556-z (2020).","journal-title":"Nat. Commun."},{"key":"57929_CR39","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.cmet.2018.10.001","volume":"29","author":"EM Varin","year":"2019","unstructured":"Varin, E. M. et al. Circulating levels of soluble dipeptidyl peptidase-4 are dissociated from inflammation and induced by enzymatic DPP4 inhibition. Cell. Metab. 29, 320\u2013334e325. https:\/\/doi.org\/10.1016\/j.cmet.2018.10.001 (2019).","journal-title":"Cell. Metab."},{"key":"57929_CR40","doi-asserted-by":"publisher","first-page":"3333","DOI":"10.1210\/jc.2012-1544","volume":"97","author":"A Makdissi","year":"2012","unstructured":"Makdissi, A. et al. Sitagliptin exerts an antinflammatory action. J. Clin. Endocrinol. Metab. 97, 3333\u20133341. https:\/\/doi.org\/10.1210\/jc.2012-1544 (2012).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"57929_CR41","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/s0074-7696(04)35004-7","volume":"235","author":"R Mentlein","year":"2004","unstructured":"Mentlein, R. Cell-surface peptidases. Int. Rev. Cytol. 235, 165\u2013213. https:\/\/doi.org\/10.1016\/s0074-7696(04)35004-7 (2004).","journal-title":"Int. Rev. Cytol."},{"key":"57929_CR42","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1210\/er.2014-1035","volume":"35","author":"EE Mulvihill","year":"2014","unstructured":"Mulvihill, E. E. & Drucker, D. J. Pharmacology, physiology, and mechanisms of action of dipeptidyl peptidase-4 inhibitors. Endocr. Rev. 35, 992\u20131019. https:\/\/doi.org\/10.1210\/er.2014-1035 (2014).","journal-title":"Endocr. Rev."},{"key":"57929_CR43","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1021\/jm400658e","volume":"57","author":"L Juillerat-Jeanneret","year":"2014","unstructured":"Juillerat-Jeanneret, L. Dipeptidyl peptidase IV and its inhibitors: therapeutics for type 2 diabetes and what else? J. Med. Chem. 57, 2197\u20132212. https:\/\/doi.org\/10.1021\/jm400658e (2014).","journal-title":"J. Med. Chem."},{"key":"57929_CR44","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1016\/j.jid.2024.03.020","volume":"144","author":"KA Zeyer","year":"2024","unstructured":"Zeyer, K. A. et al. Dipeptidyl peptidase-4-mediated fibronectin processing evokes a profibrotic extracellular matrix. J. Invest. Dermatol. 144, 2477\u20132487e2413. https:\/\/doi.org\/10.1016\/j.jid.2024.03.020 (2024).","journal-title":"J. Invest. Dermatol."},{"key":"57929_CR45","doi-asserted-by":"publisher","unstructured":"Seo, H. Y. et al. Evogliptin directly inhibits inflammatory and fibrotic signaling in isolated liver cells. Int. J. Mol. Sci. 23 https:\/\/doi.org\/10.3390\/ijms231911636 (2022).","DOI":"10.3390\/ijms231911636"},{"key":"57929_CR46","doi-asserted-by":"publisher","first-page":"549","DOI":"10.59249\/rhuf5686","volume":"96","author":"M Pradhan","year":"2023","unstructured":"Pradhan, M. & Pethe, P. The molecular mechanisms involved in the hypertrophic scars post-burn injury. Yale J. Biol. Med. 96, 549\u2013563. https:\/\/doi.org\/10.59249\/rhuf5686 (2023).","journal-title":"Yale J. Biol. Med."},{"key":"57929_CR47","doi-asserted-by":"publisher","first-page":"e2301295","DOI":"10.1002\/smtd.202301295","volume":"8","author":"P Wang","year":"2024","unstructured":"Wang, P. et al. Verteporfin-loaded bioadhesive nanoparticles for the prevention of hypertrophic scar. Small Methods. 8, e2301295. https:\/\/doi.org\/10.1002\/smtd.202301295 (2024).","journal-title":"Small Methods"},{"key":"57929_CR48","doi-asserted-by":"publisher","unstructured":"Deshmukh, A. P. et al. Identification of EMT signaling cross-talk and gene regulatory networks by single-cell RNA sequencing. Proc. Natl. Acad. Sci. U S A. 118 https:\/\/doi.org\/10.1073\/pnas.2102050118 (2021).","DOI":"10.1073\/pnas.2102050118"},{"key":"57929_CR49","doi-asserted-by":"publisher","unstructured":"Cui, H. S. et al. Methionine restriction attenuates scar formation in fibroblasts derived from patients with post-burn hypertrophic scar. Int. J. Mol. Sci. 26 https:\/\/doi.org\/10.3390\/ijms26125876 (2025).","DOI":"10.3390\/ijms26125876"},{"key":"57929_CR50","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1007\/s40618-020-01455-7","volume":"44","author":"X Hu","year":"2021","unstructured":"Hu, X. et al. DPP4 gene silencing inhibits proliferation and epithelial-mesenchymal transition of papillary thyroid carcinoma cells through suppression of the MAPK pathway. J. Endocrinol. Invest. 44, 1609\u20131623. https:\/\/doi.org\/10.1007\/s40618-020-01455-7 (2021).","journal-title":"J. Endocrinol. Invest."},{"key":"57929_CR51","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1007\/s43440-023-00496-y","volume":"75","author":"CW Huang","year":"2023","unstructured":"Huang, C. W., Lee, S. Y., Du, C. X. & Ku, H. C. Soluble dipeptidyl peptidase-4 induces epithelial-mesenchymal transition through tumor growth factor-\u03b2 receptor. Pharmacol. Rep. 75, 1005\u20131016. https:\/\/doi.org\/10.1007\/s43440-023-00496-y (2023).","journal-title":"Pharmacol. Rep."},{"key":"57929_CR52","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1038\/s12276-020-00512-8","volume":"52","author":"S Seo","year":"2020","unstructured":"Seo, S. et al. Evogliptin, a dipeptidyl peptidase-4 inhibitor, attenuates pathological retinal angiogenesis by suppressing vascular endothelial growth factor-induced Arf6 activation. Exp. Mol. Med. 52, 1744\u20131753. https:\/\/doi.org\/10.1038\/s12276-020-00512-8 (2020).","journal-title":"Exp. Mol. Med."},{"key":"57929_CR53","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1002\/ddr.21966","volume":"83","author":"Z Shao","year":"2022","unstructured":"Shao, Z., Li, X., Xu, X. & Chen, P. DPP-4 inhibitor linagliptin ameliorates imiquimod-induced psoriasis-like skin alterations in type 2 diabetic mice by inhibiting the MAPK\/NF-\u03baB inflammatory pathway. Drug Dev. Res. 83, 1373\u20131382. https:\/\/doi.org\/10.1002\/ddr.21966 (2022).","journal-title":"Drug Dev. Res."},{"key":"57929_CR54","doi-asserted-by":"publisher","first-page":"368703","DOI":"10.1155\/2014\/368703","volume":"2014","author":"NH Kim","year":"2014","unstructured":"Kim, N. H., Yu, T. & Lee, D. H. The nonglycemic actions of dipeptidyl peptidase-4 inhibitors. Biomed. Res. Int. 2014, 368703. https:\/\/doi.org\/10.1155\/2014\/368703 (2014).","journal-title":"Biomed. Res. Int."},{"key":"57929_CR55","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/cac2.12392","volume":"43","author":"Z Fang","year":"2023","unstructured":"Fang, Z. et al. Signaling pathways in cancer-associated fibroblasts: recent advances and future perspectives. Cancer Commun. (Lond). 43, 3\u201341. https:\/\/doi.org\/10.1002\/cac2.12392 (2023).","journal-title":"Cancer Commun. (Lond)"},{"key":"57929_CR56","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s00018-025-05613-z","volume":"82","author":"B Liu","year":"2025","unstructured":"Liu, B. et al. circ0066187 promotes pulmonary fibrogenesis through targeting STAT3-mediated metabolism signal pathway. Cell. Mol. Life Sci. 82, 79. https:\/\/doi.org\/10.1007\/s00018-025-05613-z (2025).","journal-title":"Cell. Mol. Life Sci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57929-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57929-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57929-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T11:05:26Z","timestamp":1788433526000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57929-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,16]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["57929"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-57929-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,16]]},"assertion":[{"value":"4 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The patients provided informed consent and willingly agreed to participate in the study, as evidenced by a signed written consent form.","order":1,"name":"Ethics","label":"Informed consent statement","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research was approved by the Ethics Committee (registration number\u20142024-05-012) of Hallym University Kangdong Sacred Heart Hospital, Seoul, Republic of Korea.","order":2,"name":"Ethics","label":"Institutional review board statement","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"27592"}}